員.png)
QQ交談
您所在位置：請輸入產(chǎn)品關(guān)鍵字：
郵編：100083
聯(lián)系人：尤女士
電話：4008858216
傳真：
手機(jī)：13581534696
留言：發(fā)送留言
個(gè)性化：www.qbiotec.com
網(wǎng)址：www.qbiotec.com
商鋪：http://apwanrong.com/st289923/
kamiya biomedical COMPANY生化試劑目錄
- 發(fā)布日期：
- 有效日期：
- 所 在 地：
- 產(chǎn) 地：
- 已獲點(diǎn)擊：
- 2024年10月29日
- 2025年4月29日
- 北京北京市
- 美國
- 214次
【產(chǎn)品簡介】
【詳細(xì)說明】
KAMIYA BIOMEDICAL COMPANY于1983年在美國加利福尼亞州Thousand Oaks成立。公司長期致力于為生命科學(xué)和醫(yī)藥科學(xué)領(lǐng)域提供高質(zhì)量、創(chuàng)新性研究和診斷產(chǎn)品。KAMIYA公司zui早的產(chǎn)品為用于信號轉(zhuǎn)導(dǎo)研究用蛋白酶抑制劑staurosporine和K252a。1990年，KAMIYA公司成為*抗Fas單克隆抗體生產(chǎn)商。如今，KAMIYA公司生產(chǎn)數(shù)千種用于臨床前診斷和檢測用人源和動(dòng)物源性生物標(biāo)志物，是zui大的ELISA試劑提供商之一。KAMIYA還提供包括酶抑制劑和單克隆/多克隆抗體等多種生命科學(xué)研究用產(chǎn)品，涉及凋亡、多藥抗性(multidrug resistance)、氧化/DNA損傷與修復(fù)、骨生物學(xué)、腫瘤、心血管、炎癥、應(yīng)激、肥胖和糖尿病等學(xué)科和領(lǐng)域。早在1993年，KAMIYA就設(shè)立了臨床診斷和研究用免疫產(chǎn)品線，生產(chǎn)基于免疫投射比濁法(immunoturbidimetric technology)的脂含量、凝血、炎癥、糖尿病、營養(yǎng)評估和血清蛋白檢測試劑。其開發(fā)的標(biāo)準(zhǔn)化生化分析用K-ASSAY試劑，不需要混合、溶解和稀釋等繁瑣準(zhǔn)備步驟。zui近，KAMIYA開發(fā)了包括胰島素，D-二聚體(D-Dimer)，Factor XIII，纖維蛋白原降解產(chǎn)物(Plasma FDP)，血清/尿液FPD及FDP-E(纖維蛋白原降解產(chǎn)物E片段)和總IgE等物質(zhì)的K-ASSAY生化檢測、分析試劑。
當(dāng)前，KAMIYA擁有全美zui全的血清蛋白免疫檢測試劑。為包括醫(yī)院、醫(yī)療中心、臨床實(shí)驗(yàn)室、診斷設(shè)備生產(chǎn)商和研究單位等眾多機(jī)構(gòu)提供專業(yè)化的、性能的臨床診斷和科研用品。
kamiya biomedical company生物化學(xué)試劑產(chǎn)品目錄如下：
Cat No |
Product Name | Quantity | |
AB-001 | Pan Caspase Inhibitor (Z-VAD(OMe)-FMK) | 5 mg |
AB-002 | Granzyme B Inhibitor (Z-AAD-CMK) | 5 mg |
AB-003 | Caspase-3 / CPP32 Inhibitor (Z-DEVD-FMK) | 5 mg |
AB-004 | Caspase-8/FLICE. | 3 mg |
AB-007 | Caspase-6 Inhibitor (Z-VEID-FMK) | 3 mg |
AB-008 | Caspase-2, 3 Inhibitor (Z-VDVAD-FMK) | 3 mg |
AB-009 | Caspase-1,4,5 Inhibitor (Z-WEHD-FMK) | 1 mg |
AB-010 | Caspase-4,5,9 Inhibitor (Z-LEHD-FMK) | 1 mg |
AB-011 | Caspase-1 / ICE Inhibitor 2 (Z-YVAD-FMK) | 3 mg |
AB-014 | Biotin-VAD-FMK, Pan-Caspase Inhibitor | 1 mg |
AB-015 | BOC-D-FMK | 5 mg |
AB-021 | Caspase-13 Inhibitor (Z-LEED-FMK) | 3 mg |
AB-022 | Z-AEVD-FMK | 3 mg |
AB-024 | Caspase-1/ICE Inhibitor 2 -CHO (Ac-YVAD-CHO) | 5 mg |
AB-025 | Caspase-3/CPP32 Inhibitor -CHO (Ac-DEVD-CHO) | 5 mg |
AB-026 | Caspase-8/FLICE Inhibitor-CHO (Ac-IETD-CHO) | 5 mg |
AB-027 | Caspase-6 Inhibitor-CHO (Ac-VEID-CHO) | 5 mg |
AB-028 | Caspase Inhibitor Q-VD-OPH | 5 mg |
AB-045 | Biotin-A-A-Phep(Oph)2 | 5 mg |
AB-046 | MeOSuc-A-A-Phep(OPh)2 | 5 mg |
AB-047 | MeOSuc-A-A-P-Phep(Oph)2 | 5 mg |
AB-050 | Calpain Inhibitor 1 (Z-LLY-FMK) | 3 mg |
AB-051 | Calpain Inhibitor 2 (Mu-F-hF-FMK) | 5 mg |
AB-052 | MMP Inhibitor-1 | 5 mg |
AB-053 | Beta-Secretase Inhibitor | 3 mg |
AB-054 | Gamma-Secretase Inhibitor | 3 mg |
AB-055 | SH-5 | 1 mg |
AB-056 | SH-6 | 1 mg |
AB-057 | Ac-VAD-CHO | 5 mg |
AC-001 | Caspase-1 / ICE Fluorogenic Substrate 2 (Ac-YVAD-AFC) | 10 mg |
AC-003 | Caspase-3 / CPP32 Fluorogenic Substrate (Ac-DEVD-AFC) | 10 mg |
AC-004 | Caspase-8 / FLICE Fluorogenic Substrate (Ac-IETD-AFC) | 5 mg |
AC-007 | Caspase-6 Fluorogenic Substrate (Ac-VEID-AFC) | 10 mg |
AC-008 | Caspase-2, 3 Fluorogenic Substrate (Ac-VDVAD-AFC) | 5 mg |
AC-010 | Caspase-4,5,9 Fluorogenic Substrate (Ac-LEHD-AFC) | 5 mg |
AC-021 | Caspase-1 / ICE Fluorogenic Substrate 1 (Ac-VAD-AFC) | 5 mg |
AC-023 | Caspase-1/ICE Substrate 2-pNA (Ac-YVAD-pNA) | 25 mg |
AC-024 | Caspase-3/CPP32 Substrate-pNA (Ac-DEVD-pNA) | 25 mg |
AC-025 | Caspase-8 Substrate-pNA (Ac-IETD-pNA) | 25 mg |
AC-026 | Caspase-6 Substrate-pNA (Ac-VEID-pNA) | 25 mg |
AC-027 | Caspase-2,3 Substrate -pNA (Ac-VDVAD-pNA) | 25 mg |
AC-028 | Caspase-4,5,9 Substrate -pNA (Ac-LEHD-pNA) | 25 mg |
AC-029 | Caspase-1,4,5 Substrate -pNA (Ac-WEHD-pNA) | 25 mg |
AC-030 | Granzyme B Substrate 2-pNA (Ac-IEPD-pNA) | 25 mg |
AC-051 | MMP Substrate-1 | 5 mg |
AC-052 | MMP Substrate-2 | 3 mg |
AC-053 | MMP Substrate-3 | 3 mg |
AC-054 | MMP Substrate-4 | 3 mg |
AC-055 | MMP Substrate-5 | 3 mg |
AC-056 | MMP Substrate-6 | 3 mg |
AC-058 | Alpha-Secretase Substrate-2 | 1 mg |
AC-059 | Beta-Secretase Substrate-1 | 1 mg |
AC-060 | Beta-Secretase Substrate-2 | 1 mg |
AC-062 | Gamma-Secretase Substrate-2 | 1 mg |
AC-063 | Granzyme B Fluorogenic Substrate (Ac-IEDP-AFC) | 10 mg |
AC-064 | Caspase-1/ICE Substrate pNA (Ac-VAD-pNA) | 25 mg |
AD-003 | Caspase-3 / CPP32 Inhibitor / Biotin Tag (Biotin-DEVD-FMK) | 1 mg |
AD-012 | Caspase Inhibitor Negative Control / Biotin Tag (Cathepsin B Inhibitor / Biotin Tag) (Biotin-FA-FMK) | 5 mg |
AE-001 | Caspase Inhibitor Negative Control (Cathepsin B Inhibitor) (Z-FA-FMK) | 5 mg |
AF-016 | Fas Ligand [CD95 Ligand] Inhibitor | 50 μg |
AP-002 | Staurosporine | 1 mg |
AP-005 | Swinholide A | 10 μg |
AP-006 | Fostriecin | 10 μg |
BC-008 | EDG-1 Blocking Peptide | 50 ug |
BC-009 | EDG-1 Control | 100 uL |
BC-010 | EDG-2 Blocking Peptide | 50 ug |
BC-011 | EDG-2 Control | 100 uL |
BC-012 | EDG-4 Control | 100 uL |
BC-013 | EDG-6 Blocking Peptide | 50 ug |
BC-014 | EDG-6 Control | 100 uL |
BC-015 | EDG-7 Blocking Peptide | 50 ug |
BC-016 | EDG-7 Control | 100 uL |
BC-017 | EDG-8 Blocking Peptide | 50 ug |
BC-027 | CD40L, human recombinant | 50 ug |
BC-031 | JC-1, Iodide | 5 mg |
BC-032 | PARP-1, human recombinant | 20 ug |
BC-033 | PARP-2, mouse recombinant | 20 ug |
BC-034 | DAF-2 DA | 1 mg |
BC-039 | DAR-4M AM (Cell Permeable) | 1 mg |
BC-052 | [Boc-Asp(Obzl)-Lys(z)-OtBu], Reversin 121 | 5 mg |
BC-082 | TWEAK | 10 ug |
BC-088 | Sophoricoside, IL-5 Inhibitor | 10 mg |
BC-090 | PGP-4008, P-GP Inhibitor | 2 mg |
BC-091 | TRAIL-His tag, soluble (human recombinant) | 20 ug |
BC-113 | C75 | 5 mg |
BC-114 | ACRP30 headless, human | 10 ug |
BC-116 | Caspase-1, human recombinant, active | 25 U |
BC-117 | Caspase-1, human recombinant, active | 100 U |
BC-118 | Caspase-2, human recombinant, active | 25 U |
BC-119 | Caspase-2, human recombinant, active | 100 U |
BC-120 | Caspase-4, human recombinant, active | 25 U |
BC-121 | Caspase-4, human recombinant active | 100 U |
BC-122 | Caspase-5, human recombinant, active | 25 U |
BC-123 | Caspase-5, human recombinant, active | 100 U |
BC-124 | Caspase-9, human recombinant, active | 25 U |
BC-125 | Caspase-9, human recombinant | 100 U |
BC-126 | Granzyme A, human recombinant | 10 ug |
BC-127 | Granzyme K, human recombinant | 10 ug |
BC-128 | ACRP30, mouse recombinant | 50 ug |
BC-144 | Epitope/Affinity Tag Positive Control | 0.2 mL |
BC-151 | Histone Protein | 10 ug |
BC-152 | Hela Nuclear Extract | 1 mg |
BC-153 | Adiponectin, human, recombinant | 25 ug |
BC-154 | Adiponectin, mouse, recombinant | 25 ug |
BC-155 | Adiponectin, rat, recombinant | 25 ug |
BC-236 | BMPR-1A | 100 ug |
BC-251 | Leptin, human recomb. | 1 mg |
BC-255 | Chetomin | 1 mg |
BC-257 | EB-47.2HCl.2H2O | 5 mg |
BC-258 | BNP, human recombinant | 10 ug |
BC-259 | Flt3-L, human recombinant | 10 ug |
BC-260 | Flt3-L, mouse recombinant | 10 ug |
BC-261 | Growth Hormone (GH), Ovine recombinant | 100 ug |
BC-262 | Growth Hormone (GH), rat recombinant | 100 ug |
BC-263 | IGF-I, human recombinant | 100 ug |
BC-264 | IGF-I, mouse recombinant | 50 ug |
BC-265 | IGF-I, rat recombinant | 50 ug |
BC-266 | IGF-II, human recombinant | 50 ug |
BC-269 | IGFBP-3, human recombinant | 25 ug |
BC-270 | IL-1alpha, human recombinant | 10 ug |
BC-271 | IL-1 beta, human recombinant | 10 ug |
BC-272 | IL-2 beta, mouse recombinant | 10 ug |
BC-274 | IL-2, human recombinant | 50 ug |
BC-275 | IL-3, human recombinant | 10 ug |
BC-276 | IL-4, human recombinant | 10 ug |
BC-277 | IL-4 mouse recombinant | 10 ug |
BC-278 | IL-5, human recombinant | 10 ug |
BC-279 | IL-6, human recombinant | 20 ug |
BC-280 | IL-6, mouse recombinant | 10 ug |
BC-281 | IL-7, human recombinant | 10 ug |
BC-282 | IL-9, human recombinant | 10 ug |
BC-284 | IL-11, human recombinant | 10 ug |
BC-285 | IL-15, human recombinant | 10 ug |
BC-286 | IL-15, mouse recombinant | 10 ug |
BC-287 | IL-15, rat recombinant | 10 ug |
BC-290 | IL-20, human recombinant | 10 ug |
BC-291 | IL-22, human recombinant | 10 ug |
BC-292 | Stem Cell Factor (SCF), human recombinant | 10 ug |
BC-293 | Stem Cell Factor (SCF) mouse recombinant | 10 ug |
BC-294 | Stem Cell Factor (SCF) rat recombinant | 10 ug |
BC-295 | VEGF, human recombinant | 10 ug |
BC-297 | VEGF, mouse recombinant | 10 ug |
BC-298 | MIP-1alpha, human recombinant | 20 ug |
BC-299 | MIP-1 alpha, mouse recombinant | 10 ug |
BC-300 | MIP-1beta, human recombinant | 10 ug |
BC-302 | MIP-3 beta, human recombinant | 20 ug |
BC-303 | MIP-4, human recombinant | 10 ug |
BC-304 | Insulin, human recombinant | 250 mg |
BC-305 | VEGF121, human recombinant | 10 ug |
BC-306 | Thapsigargin | 1 mg |
BC-307 | MIA | 20 ug |
BC-308 | YC-1 | 25 mg |
BC-311 | Visfatin, soluble, human recombinant, His | 50 ug |
BC-312 | Visfatin, soluble, mouse recombinant, His | 50 ug |
BC-313 | Aristoforin | 1 mg |
BC-314 | DICA | 25 mg |
BC-315 | Fn14(mouse):Fc | 50 ug |
BC-316 | Apotosis Activator 2 | 25 mg |
BC-317 | Fn14(mouse):Fc-FITC | 50 ug |
BC-318 | Carboxy-PTIO | 50 mg |
BC-319 | Fn14(human):Fc | 50 ug |
BC-320 | PARP-3 human recombinant | 20 ug |
BC-321 | BAFF (human recombinant soluble) | 10 ug |
BC-322 | BAFF(mouse recombinant soluble) | 10 ug |
BC-323 | BAFF-R(human):Fc(human) | 50 ug |
BC-324 | BAFF-R(mouse):Fc(human) recombinant | 50 ug |
BC-325 | Go 6976 | 0.5 mg |
BC-327 | BES-H2O2 | 1 mg |
BC-328 | PQ401 | 5 mg |
BC-329 | Omentin 1, human recombinant | 10 ug |
BC-331 | ETB | 200 ug |
BC-332 | Reveromycin A Sodium Salt | 500 ug |
BC-333 | RKTS-33 | 200 ug |
BC-334 | Tryprostatin A | 500 ug |
BC-338 | rMMP-7, human recombinant | 0.1 mg |
BC-339 | rPro-MMP-7, human recombinant | 0.1 mg |
BC-340 | Glutaredoxin 1 (Human) | 0.1 mg |
BC-341 | Glutathione Peroxidase 4 (Human) | 0.5 mg |
BC-342 | Peroxiredoxin 1 (Human) | 0.25 mg |
BC-343 | Peroxiredoxin 2 (Human) | 0.2 mg |
BC-344 | Peroxiredoxin 3 (Human) | 0.25 mg |
BC-345 | Ghrelin (human) | 0.1 mg |
BC-346 | Ghrelin (rat) | 0.1 mg |
BC-347 | Des-Acyl Ghrelin (human) | 0.1 mg |
BC-348 | Des-Acyl Ghrelin (rat) | 0.1 mg |
BP-002 | Osteoprotegerin (rhOPG:Fc) | 50 ug |
BP-010 | Osteocalcin, Bovine | 100 ug |
BP-011 | Osteocalcin, Human | 20 ug |
BP-012 | Osteonectin, Bovine | 50 ug |
BP-013 | Osteonectin, Humen | 50 ug |
BP-016 | BMP-7 (human recombinant) | 10 ug |
BP-018 | RANK:Fc | 50 ug |
BP-022 | BMP-7 CHO, human recombinant | 10 ug |
BP-023 | ProBMP-2, human recombinant | 10 ug |
BP-024 | GDF5, human recombinant | 50 ug |
BP-025 | AITRL (Osteostat), human recombinant | 20 ug |
BP-026 | BMP Receptor Type IA | 10 ug |
BP-027 | Elcatonin | 1 mg |
BP-028 | Eptifabatide, human | 25 mg |
CR-001 | CrmA | 100 μg |
EN-002 | Caspase-6, human recombinant | 5 μg |
EN-005 | Caspase-7 | 5 μg |
EN-007 | Granzyme B, human, natural | 10 ug |
EN-008 | Perforin, human, natural | 1 ug |
FL-101 | Fas Ligand Protein, soluble | 10 μg |
FL-103 | Fas Ligand, Soluble Human (no enhancer required) | 5 ug |
FL-104 | sFas Ligand Enhancer | 1 x 50 ug |
KT-375 | Herbimycin A | 1 mg |
LC-519 | Lactacystin | 1 mg |
MT-100 | Okadaic Acid (Free Acid) | 100 μg |
MT-800 | Bafilomycin A1 | 100 μg |
MT-804 | Bafilomycin A1 | 1 mg |
TN-001 | TNF-alpha, Soluble (mouse recombinant) | 50 μg |
TN-002 | TNF-alpha, soluble (human recombinant) | 50 μg |
TN-003 | TNF-R1(human) | 50 μg |
TN-004 | TNF-R2 (human) | 50 μg |
TR-004 | TRAIL-R1, Human Recombinant Protein | 50 μg |
TR-005 | TRAIL-R2, Human Recombinant Protein | 50 μg |
TR-006 | TRAIL-R2, Human Recombinant Protein (FITC labeled) | 50 μg |
TR-007 | TRAIL-R3, Human Recombinant Protein | 50 μg |
TR-008 | TRAIL-R4,Human Recombinant Protein | 50 μg |